GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NetScientific PLC (STU:NTK1) » Definitions » Long-Term Capital Lease Obligation

NetScientific (STU:NTK1) Long-Term Capital Lease Obligation : €0.24 Mil (As of Jun. 2023)


View and export this data going back to 2020. Start your Free Trial

What is NetScientific Long-Term Capital Lease Obligation?

NetScientific's Long-Term Capital Lease Obligation for the quarter that ended in Jun. 2023 was €0.24 Mil.

NetScientific's quarterly Long-Term Capital Lease Obligation increased from Jun. 2022 (€0.13 Mil) to Dec. 2022 (€0.31 Mil) but then declined from Dec. 2022 (€0.31 Mil) to Jun. 2023 (€0.24 Mil).

NetScientific's annual Long-Term Capital Lease Obligation declined from Dec. 2020 (€0.18 Mil) to Dec. 2021 (€0.15 Mil) but then increased from Dec. 2021 (€0.15 Mil) to Dec. 2022 (€0.31 Mil).


NetScientific Long-Term Capital Lease Obligation Historical Data

The historical data trend for NetScientific's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NetScientific Long-Term Capital Lease Obligation Chart

NetScientific Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.23 0.18 0.15 0.31

NetScientific Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.15 0.13 0.31 0.24

NetScientific  (STU:NTK1) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

NetScientific Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of NetScientific's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


NetScientific (STU:NTK1) Business Description

Industry
Traded in Other Exchanges
Address
20 Saint Andrew Street, Holborn Circus, London, GBR, EC4A 3AG
NetScientific PLC is a transatlantic healthcare technology company. The group is focused on sourcing, funding and commercializing technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people. Its portfolio consists of WANDA Health, an analytics company that uses machine learning to derive a personalized risk score for Congestive Heart Failure patients, Glucosense a provider of a non-invasive glucose monitoring wearable device, Vortex Biosciences which is engaged in circulating tumor cell identification, selection and analysis for disease monitoring and personalized therapeutic prescribing, and Glycotest which provides non-invasive blood tests for liver cancers and fibrosis-cirrhosis.

NetScientific (STU:NTK1) Headlines

No Headlines